Hong Kong Stock Market Midday Review | Hang Seng Index rose 1.7% in the morning session, Xiaomi Group surged over 8%

Zhitong
2026.05.04 04:03

The Hong Kong Hang Seng Index rose 1.7% in the morning session, reporting 26,215 points, with a turnover of HKD 107.6 billion. Xiaomi Group rose over 8%, with April delivery exceeding 30,000 units and over 70,000 pre-orders for the new generation SU7. Chip stocks performed strongly, with ILUVATAR COREX rising over 15%. Domestic property stocks collectively rose, with CHINA VANKE increasing over 7%. Zhongjiao Holdings fell over 9% after earnings

According to Zhitong Finance APP, the Hong Kong Hang Seng Index rose by 1.7%, up 438 points, closing at 26,215 points; the Hang Seng Tech Index increased by 2.86%. The turnover of Hong Kong stocks in the morning session reached HKD 107.6 billion.

Chip stocks led the gains. ILUVATAR COREX (09903) rose over 15%, as domestic computing chip companies entered a critical period for performance realization. Montage Technology (06809) rose by 3%; Bairun Technology (06082) increased by 4%.

A research report released by Shanxi Securities shows that the optical communication industry is experiencing strong catalysts due to the reflective effect of high prosperity in overseas industrial chains. Xizhi Technology-P (01879) rose over 20%; Cambridge Technology (06166) increased by over 14%.

Weichai Power (02338) rose over 12%, reaching a new high, with first-quarter data center product sales increasing by over 240% year-on-year.

XIAOMI-W (01810) rose over 8%, leading blue chips, with Xiaomi Auto's April delivery exceeding 30,000 units, and orders for the new generation SU7 surpassing 70,000.

Qunkong Technology (00068) rose over 15%, having signed a strategic cooperation framework agreement with Jinyong Investment.

Deshi-B (02526) rose over 13%, setting a new high since its listing, showcasing its self-developed iMedImage® medical imaging base model at the Canton Fair.

Wuyi Vision (06651) rose over 7%, as the company granted 940,000 RSUs for the first time to align the interests of its core team.

Dongyang Sunshine Pharmaceutical (06887) rose over 13%, as its self-developed insulin glargine injection received approval for listing from the U.S. FDA.

Domestic property stocks rose collectively. CHINA VANKE (02202) rose over 7%, as new real estate policies were announced in cities like Shenzhen and Guangzhou.

China Heart-to-Heart Fertilizer (01866) rose over 13%, with new production capacity expected to drive explosive growth in performance.

Guofu Quantum (00290) rose over 10%, as the company plans to acquire a stake in Luffa AI.

Zhongjiao Holdings (00839) fell over 9% after earnings, with mid-term net profit declining nearly 22% year-on-year to CNY 757 million

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.